V. Moulin

发表

Sequential Treatment With Trifluridine/Tipiracil and Regorafenib in Refractory Metastatic Colorectal Cancer Patients: An AGEO Prospective "Real-World Study".

O. Bouché, D. Vernerey, J. Taieb, 2022, Clinical colorectal cancer.

Efficacy and Safety of Aflibercept in Combination With Chemotherapy Beyond Second-Line Therapy in Metastatic Colorectal Carcinoma Patients: An AGEO Multicenter Study.

D. Vernerey, P. Hammel, J. Taieb, 2020, Clinical colorectal cancer.

Prognosis and chemosensitivity of deficient MMR phenotype in patients with metastatic colorectal cancer: An AGEO retrospective multicenter study

D. Vernerey, J. Taieb, R. Coriat, 2020, International journal of cancer.

Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal Cancers

J. Sabourin, R. Guimbaud, M. Auriault, 2022, International journal of molecular sciences.

Prognostic factors of Colorectal Cancer patients with Brain Metastases.

A. Lièvre, D. Tougeron, J. Bennouna, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

HSP110 as a Diagnostic but Not a Prognostic Biomarker in Colorectal Cancer With Microsatellite Instability

M. Auriault, J. Godet, E. Miquelestorena-Standley, 2022, Frontiers in Genetics.

Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: A French comprehensive multicentre ambispective observational cohort study (CAPANCOVID)

S. Truant, C. Borg, G. Piessen, 2022, European Journal of Cancer.

Heterogeneity of mismatch repair defect in colorectal cancer and its implications in clinical practice.

Qing Wang, M. Auriault, J. Godet, 2018, European journal of cancer.

533PA large retrospective multicenter study evaluating prognosis and chemosensitivity of metastatic colorectal cancer with microsatellite instability

J. Taieb, R. Coriat, T. André, 2017 .

FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX‐bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter study

C. Tournigand, M. Perrier, D. Botsen, 2022, International journal of cancer.

Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study.

I. Sobhani, J. Taïeb, F. Bonnetain, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations.

E. Vasile, A. Lièvre, W. Cacheux, 2019, European journal of cancer.

A large multicenter study evaluating prognosis and chemosensitivity of metastatic colorectal cancers with microsatellite instability.

J. Taieb, R. Coriat, D. Tougeron, 2017 .